13-Aug-2026
Download PDF
Omkar Pharmachem
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 13 August 2026 has considered and approved the following business:1. Unaudited Financial Results of the Company alongwith Limited Review Report for the quarter ended on 30" June 2026.
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
